Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
Health plans’ coverage of the medication, branded as Wegovy — which has a $1,300-a-month price tag — is not a sure thing.
All Coverage
-
-
Bus Stop by Bus Stop, Denver-Area Officials Microtarget Vaccine Hesitancy
Using detailed maps that show vaccination rates down to the ZIP code or census tract level, health departments highlight areas of greater Denver where vaccinations lag behind state or county averages, then partner with community organizations to overcome barriers. Can this be a model for President Joe Biden’s “neighborhood by neighborhood” approach?
-
Amid Covid Booster Debate, West Virginia to Check Immunity of Vaccinated Nursing Home Residents
The state says it will look at the levels of disease-fighting antibodies among nursing home residents vaccinated against covid, which could help indicate whether they need a booster shot.
-
KHN’s ‘What the Health?’: Hot Covid Summer
The summer that promised to let Americans resume a relatively normal life is turning into another summer of anxiety and face masks, as the delta variant drives covid caseloads up in all 50 states. Meanwhile, the Americans with Disabilities Act turns 35, and the Missouri Supreme Court orders the state to expand Medicaid after all. Mary Ellen McIntire of CQ Roll Call, Anna Edney of Bloomberg News and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Samantha Young, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about an Olympic-level athlete with an Olympic-size medical bill.
-
Olympic Dream Dashed After Bike Crash and Nightmare Medical Bill Over $200K
A bicyclist from California competed in a Pennsylvania race that could have landed him in this month’s Tokyo Olympics. Instead, a crash on the velodrome track landed him in two hospitals where his out-of-state, out-of-network surgeries garnered huge bills.
-
Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
-
Covid Renews Interest in Radiation, but Docs Caution Against Pilgrimages to Radon-Filled Mines
Each year, people in pain travel to Montana and pay to sit amid radon gas, which is pitched as therapy for a long list of health issues. While low-dose radiation therapy is getting another look amid the pandemic, experts say that treatment is different than sitting in a tunnel of radioactive gas.
-
Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet
Scientists are trying to piece together why the delta variant so readily infects unvaccinated Americans, spewing 1,000 times more virus particles.
-
Women Say California Insurer Makes It Too Hard to Get Drug for Postpartum Depression
Brexanolone is a promising new treatment for postpartum depression. But one insurer’s requirement that women try four other drugs and electroconvulsive therapy before the infusion means it is out-of-reach for millions of women.
-
Sign-Up Window for Free COBRA Coverage for Many Laid-Off Workers Closes This Week
The most recent covid relief law offered federal funding to pay insurance premiums for workers who lost their jobs and opted to keep their workplace insurance through COBRA. But the window to take advantage of the subsidized coverage is closing: Many workers would need to enroll in the program by July 31.
-
Bye-Bye to Health Insurance ‘Birthday Rule’? Kansas Lawmaker Floats Fix
U.S. Rep. Sharice Davids (D-Kansas) introduced a bill to do away with a health insurance rule that dictates which parent’s plan becomes a new baby’s primary insurer. This could save some parents from unexpected, sometimes massive medical bills. Davids took up the issue after a KHN/NPR Bill of the Month story on one family’s unexpected $207,455 NICU bill.
-
How a Doctor Breaks Norms to Treat Refugees and Recent Immigrants
In a suburb of Denver, a doctor runs a clinic that finds creative solutions to treat a large refugee and immigrant population, sometimes to the dismay of the medical establishment.
-
Want Fries With That Vaccine? Even at a Fast-Food Restaurant, Pop-Up Clinics See Slow Traffic
At a pop-up vaccine clinic in a McDonald’s parking lot in the city of San Bernardino, fewer than two dozen people agreed to get a shot, offering a snapshot of the faltering vaccination effort.
-
The Pandemic Made Telemedicine an Instant Hit. Patients and Providers Feel the Growing Pains.
Patients seem to like remote visits, and health care providers now depend on them. But outages, freezing and other glitches cost time and money, and compromise quality of care.
-
As Holdout Missouri Joins Nation in Monitoring Opioid Prescriptions, Experts Worry
Missouri is the last state to create a monitoring program to help spot the misuse of prescription drugs. But some public health experts warn that the nation’s programs are forcing people addicted to opioids to seek deadlier street options.
-
Watch: More Long-Covid Cases Seen in Kids
While covid is generally mild in children, doctors report a growing number of long-haul covid symptoms and MIS-C cases, particularly among Black and Latino children.
-
Journalists Dig in on Delta Variant Risks and Opioid Overdose Deaths
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Contraception Is Free to Women, Except When It’s Not
The landmark federal health law required most commercial health plans to cover a comprehensive list of birth control methods approved by the Food and Drug Administration free of charge to female patients. But health plans don’t have to cover every option, and newer methods are not included in the federal list of covered services.
-
Readers and Tweeters Connect the Dots on Topics From Vaccine Development to Long Covid
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
